The immune risk profile and associated parameters in late life: Lessons from the OCTO and NONA longitudinal studies

Handbook on Immunosenescence: Basic Understanding and Clinical Applications

Volumn 9781402090639, Issue , 2009, Pages 3-28

  Wikby, Anders ^a   Strindhall, Jan ^a   Johansson, Boo ^a,b  

^a JÖNKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Immune risk profiles; Immunosenescence; Longitudinal studies; T cells

Indexed keywords

EID: 84892785169     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-9063-9_1     Document Type: Chapter

References (64)

1. Akbar AN, Fletcher JM (2005) Memory T-cell homeostasis and senescence during aging. Curr. Opin Immunol 17:480-485
2. Appay V, Dunbar PR, Callan M et al (2002) Memory CD8+ T-cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8:379-385
3. Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK (2003) Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol 132:24-31
4. Delarosa O, Pawelec G, Peralbo E, Wikby A, Mariani E, Mocchegiani E, Tarazona R, Solana R (2006) Immunological biomarkers of ageing in man; changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology 7:471-481
5. Effros R (2004) From Hayflick to Walford: the role of T-cell replicative senescence in human aging. Exp Gerontol 39:885-890
6. Effros RB (2007) Role of T-lymphocyte replicative senescence in vaccine efficacy. Vaccine 25:599-604
7. Evrin PE, Nilsson SE, Öberg T, Malmberg B (2005) Serum C-reactive protein in elderly men and women: association with mortality, morbidity and various biochemical values. Scand J Clin Lab Invest 65:23-31
8. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B (1995) Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison of survivors and nonsurvivors. J Gerontol Biol Sci 50 A: B378-B382
9. Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, Birch KE, Cook JE, Jackson SE, Salmon M, Rustin MH, Akbar AN (2005) Cytomegalovirus-specific CD4 +T-cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 175:8218-8225
10. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
11. Forsey RJ, Thompson JM, Ernerudh J, Hurst TL, Strindhall J, Johansson B, Nilsson BO, Wikby A (2003) Plasma cytokine profiles in elderly humans. Mech Ageing Dev 124:487-493
12. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging: an evolutionary perspective on immunosenescence. Ann NY Acad Sci 908:244-254
13. Fulop T, Larbi A, Wikby A, Mocchegiani E, Hirokawa K, Pawelec G (2005) Dysregulation of T-cell function in the elderly: scientific basis and clinical implications. Drugs Aging 22:589-603
14. Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM (2001) Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75:12182-12187
15. Hallgren HM, Bergh N, Rodysill KJ, O'Leary JJ (1988) Lymphocyte proliferative response to PHA and anti-CD3/Ti monoclonal antibodies, T-cell surface marker expression, and serum IL-2 receptor levels as biomarkers of age and health. Mech Ageing Dev 43:175-185
16. Huppert FA, Pinto EM, Morgan K, Brayne C (2003) Survival in a population sample is predicted by proportions of lymphocyte subsets. Mech Ageing Dev 124:449-451
17. Jeune B (2002) Living longer-but better? Aging Clin Exp Res 14:72-93
18. Johansson B (1988/89) The MIR-Memory in Reality Test. Stockholm, Sweden: Psykologiförlaget AB
19. Johansson B, Zarit SH, Berg S (1992) Changes in cognitive functioning of the oldest old. J Gerontol 47:P75-P80
20. Johansson B, Zarit SH (1997) Early cognitive markers of the incidence of dementia and mortality: a longitudinal population-based study of the oldest old. Int J Geriatr Psychiatry 12:53-59
21. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth, JA, Sinclair AJ, Nayak L, Moss PA (2002) Cytomegalovirus seropositivity drives the CD8 T-cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 169:1984-1992
22. Khan N, Hislop A, Gudgeon N, Cobbold M, Khanna R, Nayak L, Rickinson AB, Moss PA (2004) Herpesvirus-specific CD8 T-cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol 173:7481-7489
23. Karlamangla AS, Singer BH, McEwen BS, Rowe JW, Seeman TE (2002) Allostatic load as a predictor of functional decline: MacArthur studies of successful aging. J Clin Epidemiol 55:696-710
24. Karlamangla AS, Singer BH, Seeman TE (2006) Reduction in allostatic load in older adults is associated with lower all-cause mortality risk: MacArthur studies of successful aging. Psychosom Med 68:500-507
25. Koch S, Kempf J, Pawelec G (2005) T-CIA: investigating T-cells in aging. Sci Aging Knowledge Environ: pe21
26. Krabbe KS, Pedersen M, Bruunsgaard H (2004) Inflammatory mediators in the elderly. Exp Gerontol 39:687-699
27. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, Muller-Hermelink HK, Steinmann GG (1984) Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 28:47-55
28. McEwen BS, Stellar E (1993) Stress and the individual: mechanisms leading to disease. Arch Intern Med 153:2093-2101
29. McEwen BS (2003) Interacting mediators of allostasis and allostatic load: towards an understanding of resilience in aging. Metabolism 52:10-16
30. Marsland AL, Petersen KL, Sathanoori R, Muldoon MF, Neumann SA, Ryan C, Flory JD, Manuck SB (2006) Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers. Psychosom Med 68:895-903
31. Messaoudi I, Lemaoult J, Guevara-Patino JA, Metzner BM, Nikolich-Zugich J (2004) Age-related CD8 T-cell clonal expansions constrict CD8 T-cell repertoire and have the potential to impair immune defence. J Exp Med 200:1347-1358
32. Miller RA (2001) Biomarkers of aging: prediction of longevity by using age-sensitive T-cell subset determinations in a middle-aged, genetically heterogeneous mouse population. J Gerontol Biol Sci 56 A: B180-B186
33. Moss P, Khan N (2004) CD8+ T-cell immunity to cytomegalovirus. Human Immunol 65:456-464
34. Murasko DM, Weiner P, Kaye D (1987) Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin Exp Immunol 70:440-448
35. Nilsson BO, Ernerudh J, Johansson B, Evrin P-E, Löfgren S, Ferguson F, Wikby A (2003) Morbidity does not influence the T-cell immune risk phenotype in the elderly: findings in the Swedish NONA Immune Study using sample selection protocols. Mech Ageing Dev 124:469-476
36. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson B-O, Ferguson F (2000) Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 121:187-201
37. Ouyang Q, Wagner WM, Walter S, Muller CA, Wikby A, Aubert G, Klatt T, Stevanovic S, Dodi T, Pawelec G (2003). An age-related increase in the number of CD8+ T-cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev 124:477-485
38. Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G (2004) Dysfunctional CMV-specific CD8+ T-cells accumulate in the elderly. Exp Gerontol 39:607-613
39. Pawelec G, Ferguson F, Wikby A (2001) The SENIEUR protocol after 16 years. Mech Ageing Dev 122:132-134
40. Pawelec G, Caruso C (2003) Immunology and ageing in Europe: ImAginE-ation in the EU. Mech Ageing Dev 124:357-360
41. Pawelec G, Akbar A, Caruso C, Grubeck-Loebenstein B, Solana R, Wikby A (2005) Human immunosenescence: is it infectious? Immunol Rev 205:257-268
42. Pawelec G (2006) Immunity and ageing in man. Exp Gerontol 41:1239-1242
43. Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA (2007) The CMV-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol 81:7759-7765
44. Reker-Hadrup S, Strindhall J, Kollgaard T, Seremet T, Johansson B, Pawelec G, thor Straten P, Wikby A (2006) Longitudinal studies of clonally expanded CD8 T-cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirusspecific T-cells in the very elderly. J Immunol 176:2645-2653
45. Reuben DB, Cheh AI, Harris TB, Ferrucci L, Rowe JW, Tracy RP, Seeman TE (2002) Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 50:638-644
46. Roberts-Thomson IC, Whittingham S, Youngchaiyud U, Mackay IR (1974). Ageing, immune response and mortality. Lancet 2:368-370
47. Saurwein-Teissl M, Lung TL, Marx F, Gschösser C, Asch E, Blasko I, Parson W, Böck G, Schönitzer D, Trannoy E, Grubeck-Loebenstein B (2002) Lack of antibody production following immunization in old age: association with CD8+CD28-T-cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 168:5893-5899
48. Steensberg A., Fischer CP, Keller C, Moller K, Pedersen BK (2003) IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285:E433-E437
49. Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R (2007) Chronic herpesvirus reactivation occurs in aging. Exp Gerontol 42:563-570
50. Strindhall J, Nilsson BO, Löfgren S, Ernerudh J, Pawelec G, Johansson B, Wikby A (2007) No immune risk profile among individuals who reach 100 years of age: Findings from the Swedish NONA immune longitudinal study. Exp Gerontol 42:753-761
51. Tarkowski E (2002) Cytokines in dementias. Curr Drug Targets Inflamm Allergy 1:193-200
52. thor Straten P, Barfoed A, Seremet T, Saeterdal I, Zeuthen J, Guldberg P (1998) Detection and characterization of alpha-beta-T-cell clonality by denaturing gradient gel electrophoresis (DGGE). Biotechniques 25:244-250
53. Trzonkowski P, Mysliwska J, Szmit E, Wieckiewicz J, Lukaszuk K, Brydak LB, Machala M, Mysliwski A (2003) Associations between cytomegalovirus infection, enhanced proinflammatory response and low levels of antihemagglutinins during the antiinfluenza vaccination-an impact of immunosenescence. Vaccine 21:3826-3836
54. Wallace DL, Zhang Y, Ghattas H, Worth A, Irvine A, Bennett AR, Griffin GE, Beverley PC, Tough DF, Macallan DC (2004) Direct measurement of T-cell subset kinetics in vivo in elderly men and women. J Immunol 173;1787-1794
55. Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS (1990) Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol Med Sci 45:M45-M48
56. Vasto S, Colonna-Romano G, Larbi A, Wikby A, Caruso C, Pawelec G (2007) Role of persistent CMV infection in configuring T-cells immunity in the elderly. Immun Ageing 4:2
57. Wikby A, Johansson B, Ferguson F, Olsson J (1994) Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp Gerontol 29:531-541
58. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson F (1998) Changes in CD8 and CD4 lymphocyte subsets, T-cell proliferation responses and nonsurvival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev 102:187-198
59. Wikby A, Johansson B, Olsson J, Löfgren S, Nilsson B-O, Ferguson F (2002) Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37:445-453
60. Wikby A, Johansson B, Ferguson F (2003) The OCTO and NONA immune longitudinal studies: a review of 11 years studies of Swedish very old humans. Adv Cell Aging Gerontol 13:1-16
61. Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, Löfgren S, Nilsson B-O, Ernerudh J, Pawelec G, Johansson B (2005) An immune risk phenotype, cognitive impairment and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol Biol Sci 60A:556-565
62. Wikby A, Nilsson BO, Forsey R, Thompson J, Strindhall J, Löfgren S, Ernerudh J, Pawelec G, Ferguson F, Johansson B (2006) The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev 127:695-704
63. Wilson CJ, Finch CE, Cohen HJ (2002) Cytokines and cognition: the case for a head-to-toe inflammation paradigm. J Am Geriatr Soc 50:2041-2056
64. Zanni F, Vescovini R, Biasini C, Fagnoni F, Zanlari L, Telera A, Di Pede P, Passeri G, Pedrazzoni M, Passeri M, Franceschi C, Sansoni P (2003) Marked increase with age of Type-1 cytokines within memory and effector/cytotoxic CD8+ T-cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 38:981-987